January 14, 2019 Intelligence: Late Breaking Lab News

Up to 10,000 patients will get free genetic testing at Northwell Health, the nation’s largest urban health network. In a deal announced on Jan. 9, Northwell Health and Color, a genetic testing company, will collaborate on a program to offer genetic tests to Northwell patients as part of routine primary care. This expands an earlier pilot where 1,000 Northwell primary care patients signed up for the Color population health program. Kristen Murtos, Chief Administrative Officer at Northwell, told Health Leaders that, “Our belief … is by incorporating additional genomic data [into the care of a patient], it will position us to provide more proactive, preventative, even pre-emptive care that will result in better outcomes for our patients.”

MORE ON: Color

Last fall, Color entered into an arrangement with Jefferson Health in Philadelphia. Jefferson is offering free genetic testing to all 30,000 of its employees. Like the Northwell program, these genetic tests will look for medical conditions such as cancer and heart disease.


In the United Kingdom, the National Health Service announced plans to provide whole genome sequencing for all pediatric cancer patients. No start date was announced and a source of funding for this program is required.


    • Bio-Reference Laboratories, Inc., a division of Opko, announced the selection of Jon R. Cohen, MD, as its new Executive Chairman. Cohen was previously at Quest Diagnostics, PricewaterhouseCoopers, and North Shore-Long Island Jewish Health System.
    • Bio-Reference Laboratories, Inc., also announced that Jeff Monk moved from his position as General Manager to become President. Cohen was previously at Quest Diagnostics, Schering-Plough, and Glaxo Wellcome.
    • Cindy Perettie will become the new CEO of Foundation Medicine, effective Feb. 4. She formerly served at Roche, Genentech, Sara Cannon Research Institute, Ivax Pharmaceuticals, Elan, and Chiron Corporation.
    • Sysmex America appointed Ian Heynen as its new General Manager for Sysmex Canada. Heynen previously held positions at Profound Medical, Hologic, Sentinelle Medical, and GE Healthcare.
    • Clinical Genomics selected Betsy Hanna to be President and CEO. She has worked at Origin, Inc., J and J Vistakon, J and J Ortho-Clinical Diagnostics, and Procter and Gamble.

    That’s all the insider intelligence for this report.
    Look for the next briefing on Monday, February 4, 2019.

    dark_daily_logoHave you caught the latest e-briefings from DARK Daily? If so, then you’d know about …

    …the offer of a free whole genome sequence by Nebula Genomics to consumers. The catch is that the consumer must be willing to allow their data to be used by researchers involved in developing therapeutic drugs.

    You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.


Leave a Reply


You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.